GENE | HGNC_ID | MARKER_TYPE | CANCER_TYPE | HISTOLOGICAL_TYPE | CELL_LINE | CSC_ENRICHMENT | METHOD | EXPRESSION_LEVEL | CONFIDENCE_SCORING | GLOBAL_SCORING | PUBMED_ID |
---|
FSTL1 | 3972 | LTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC-38 | NA | SFA followed by RT-PCR and Western Blotting | NA | 0.48 | 0.0042 | 30336071
|
NANOG | 20857 | LTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC-38 | NA | SFA followed by RT-PCR and Western Blotting | NA | 0.48 | 0.5461 | 30336071
|
PROM1 | 9454 | LTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC-38 | NA | SFA followed by RT-PCR and Western Blotting | NA | 0.48 | 0.7582 | 30336071
|
SOX2 | 11195 | LTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC-38 | NA | SFA followed by RT-PCR and Western Blotting | NA | 0.48 | 0.5695 | 30336071
|
KIF11 | 6388 | LTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC-38 | Docetaxel | qRT-PCR followed by SFA | NA | 0.2 | 0.0011 | 29190901
|
ALDH1A1 | 402 | LTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC-38 | NA | ALDEFLUOR assay | NA | 0.12 | 0.684 | 19190339
|
CD24 | 1645 | LTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC-38 | Docetaxel | FACs followed by SFA | NA | 0.12 | 0.456 | 29190901
|
CD24 | 1645 | LTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC-38 | NA | FACs followed by SFA | NA | 0.12 | 0.456 | 31599500
|
CD44 | 1681 | LTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC-38 | Docetaxel | FACs followed by SFA | NA | 0.12 | 1 | 29190901
|
CD44 | 1681 | LTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC-38 | NA | FACs followed by SFA | NA | 0.12 | 1 | 31599500
|